Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific a…
Sánchez J; Claus C; Albrecht R; Gaillard BC; Marinho J; McIntyre C; Tanos T; Boehnke A; Friberg LE; Jönsson S; Frances N.
CPT Pharmacometrics Syst Pharmacol
(Unknown)
Published: 2023
Adult and pediatric physiologically-based biopharmaceutics modeling to explain lamotrigine immediate release absorption…
Caleffi-Marchesini ER; Herling AA; Macente J; Bonan RH; de Freitas Lima P; Moreno R; Alexandre V; Charbe NB; Borghi-Pangoni FB; Cristofoletti R; Diniz A.
CPT Pharmacometrics Syst Pharmacol
(Unknown)
Published: 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first ste…
Terrier J; Gaspar F; Gosselin P; Raboud O; Lenoir C; Rollason V; Csajka C; Samer C; Fontana P; Daali Y; Reny JL; OptimAT study group.
CPT Pharmacometrics Syst Pharmacol
(Unknown)
Published: 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
Néant N; Lingas G; Gaymard A; Belhadi D; Hites M; Staub T; Greil R; Paiva JA; Poissy J; Peiffer-Smadja N; Costagliola D; Yazdanpanah Y; Bouscambert-Duchamp M; Gagneux-Brunon A; Ader F; Mentré F; Wallet F; Burdet C; Guedj J; DisCoVeRy study group.
CPT Pharmacometrics Syst Pharmacol
(Unknown)
Published: 2023
How large must a dose-optimization trial be?
CPT Pharmacometrics Syst Pharmacol
(Unknown)
Published: 2023
Development and application of a PBPK modeling strategy to support antimalarial drug development.
Abla N; Howgate E; Rowland-Yeo K; Dickins M; Bergagnini-Kolev MC; Chen KF; McFeely S; Bonner JJ; Santos LGA; Gobeau N; Burt H; Barter Z; Jones HM; Wesche D; Charman SA; Möhrle JJ; Burrows JN; Almond LM.
CPT Pharmacometrics Syst Pharmacol
(Unknown)
Published: 2023